Navigointipolku

Lisätyökalut

  • Tulostettava versio
  • Pienennä tekstiä
  • Suurenna tekstiä
  • Valitse suurikontrastinen versio
  • Palauta sivun alkuperäiset värit




Rekisteröityneen profiili

International Drug Policy Consortium

Tunnistenumero rekisterissä: 75318797051-52
Rekisteröintipäivä: 1.11.2011 17:02:21

Organisaation tietoja muutettiin viimeksi 7.10.2013 16:49:15
Edellinen vuotuinen päivitys: 7.10.2013 16:49:15


Rekisteröitynyt: Organisaatio tai itsenäinen ammatinharjoittaja

Nimi tai toiminimi: International Drug Policy Consortium
Lyhenne: IDPC
Organisaation oikeudellinen muoto: Company limited by guarantee
Internet-osoite: http://www.idpc.net

Ryhmät

Ryhmä: III - Kansalaisjärjestöt
tarkemmin: Kansalaisjärjestöt, keskusteluryhmät ja verkostot ja vastaavat

Oikeudellisessa vastuussa oleva henkilö

Sukunimi, etunimi: Ann Fordham
Tehtävä organisaatiossa: Executive Director

EU-suhteista pysyvästi vastaava henkilö

Sukunimi, etunimi: Mike Trace
Tehtävä organisaatiossa: Chair

Yhteystiedot:

Organisaation päätoimipaikan yhteystiedot: City Road, 5th Floor  124-128
EC1V 2NJ London
YHDISTYNYT KUNINGASKUNTA
Puhelinnumero: (+44) 2073242975
Faksinumero: (+44) 2073242977
Muita yhteystietoja: IDPC is a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC’s vision is that national and international drug policies are grounded in the principles of human rights and human security, social inclusion, public health, development and civil society engagement.

IDPC intervenes at two levels in the decision making process: We facilitate networking and collaboration between civil society stakeholders, and seek to empower civil society and the most affected populations to better engage with and influence policy making processes. In parallel, IDPC also intervenes directly with high-level policy making processes by providing analysis and expertise to governments and UN agencies on effective and more humane drug policy options.

IDPC members promote the following policy principles in our advocacy work with national governments and international agencies:
1. Drug policies should be developed through a structured and objective assessment of priorities and evidence.
2. All activities should be undertaken in full compliance with international human rights law.
3. Drug policies should focus on reducing the harmful consequences rather than the scale of drug use and markets.
4. Policy and activities should seek to promote the social inclusion of marginalised groups, and not focus on punitive measures towards them.
5. Governments should build open and constructive relationships with civil society in the discussion and delivery of their strategies.

Tavoitteet ja tehtävät

Organisaation tavoitteet ja tehtävät: IDPC is a a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC produces briefing papers, disseminates the reports of its member organisations about particular drug-related matters, and offers expert advice to policy makers and officials around the world.

IDPC members have a wide range of experience and expertise in the analysis of drug problems and policies, and have contributed to policy debates at national and international level.

We have two main objectives:
- We provide channels for grassroots organisations to better engage with policy making processes: we facilitate communication and cooperation between civil society stakeholders, and we produce and disseminate information and materials on more effective and humane drug policies, that national and local NGOs can use in their own work. We also organise capacity building trainings to support the drug policy advocacy work of NGOs. In order to facilitate civil society engagement, we organise our work regionally.

- We draw on the knowledge within our network to offer expert advice to policy makers on how best to review their drug policies at the national and international level. The IDPC network includes many individuals who have experience of creating or reviewing government drug policies and strategies, and these individuals are available to engage in high-level discussions with policy makers.
Organisaation edustamat intressit ovat:
  • kansallisia
  • euroopanlaajuisia
  • maailmanlaajuisia

Rekisterin piiriin kuuluvaan toimintaan osallistuvien henkilöiden (jäsenet, henkilöstö jne.) lukumäärä

Henkilöiden määrä 8
Lisätietoja IDPC staff includes six full time and two part-time staff members. We also hire consultants around the world who work on thematic or regional issues related to drug policy. For more information on the IDPC team, please visit: www.idpc.net/team.

Akkreditoidut henkilöt, joilla on kulkulupa Euroopan parlamentin tiloihin

Ei akkreditoituja henkilöitä

Toimet

Tärkeimmät avoimuusrekisterin soveltamisalaan kuuluvia toimintoja koskevat EU-aloitteet edeltäneeltä vuodelta:


Over the past two years, under a grant from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities in Western and South East Europe. Throughout 2010-2011, IDPC created a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.

Since April 2011, IDPC has been involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aims to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.

IDPC also shares evidence and best practice from the EU and its member states in international forums, such as the Commission on Narcotic Drugs (CND), through the organisation of side events, the dissemination of materials and direct meetings with government delegations.

IDPC is also an active member of the European Commission Civil Society Forum on Drugs where we have engaged in drug policy debates regarding the European Union Drug Strategy and its Action Plans. Individually, IDPC has also watched closely the drafting of the new EU Drug Strategy for 2013-2020 and the Action Plan for 2013-2016. We has provided a set of recommendations, as well as organised a seminar at the European Parliament in May 2012 to ensure open discussions among representatives of EU institutions and international experts on the direction of EU drug policy for the coming years.

Intressitoimialat julkisten kuulemisten ja toteutussuunnitelmien sähköposti-ilmoituksia varten:

Organisaation ilmoittamat aihealat ovat:
  • Aluepolitiikka
  • Euroopan laajuiset verkot
  • Kansanterveys
  • Nuoret
  • Oikeusasiat ja perusoikeuksien
  • Sisäasiat
  • Ulkosuhteet
  • Viestintä

Rakenne

Jäseninä olevien luonnollisten henkilöiden lukumäärä: 106
Jäsenorganisaatioiden lukumäärä:
Jäsenorganisaatiot (Jäsenmäärä) :
Organisaatiolla on jäseniä tai se on edustettuna seuraavissa maissa:
  • ALANKOMAAT
  • BELGIA
  • BULGARIA
  • ESPANJA
  • IRLANTI
  • ITALIA
  • KREIKKA
  • KROATIA
  • LIETTUA
  • PORTUGALI
  • PUOLA
  • RANSKA
  • ROMANIA
  • RUOTSI
  • SAKSA
  • SLOVENIA
  • TANSKA
  • UNKARI
  • YHDISTYNYT KUNINGASKUNTA

  • ALBANIA
  • ARABIEMIIRIKUNNAT
  • ARGENTIINA
  • AUSTRALIA
  • BOLIVIA
  • BOSNIA JA HERTSEGOVINA
  • BRASILIA
  • CHILE
  • COSTA RICA
  • ENTINEN JUGOSLAVIAN TASAVALTA MAKEDONIA
  • GEORGIA
  • INDONESIA
  • INTIA
  • KANADA
  • KENIA
  • KOLUMBIA
  • LIBANON
  • MALESIA
  • MAURITIUS
  • MEKSIKO
  • MONTENEGRO
  • PERU
  • SAINT LUCIA
  • SERBIA
  • SVEITSI
  • THAIMAA
  • TUNISIA
  • UGANDA
  • URUGUAY
  • UUSI-SEELANTI
  • VENÄJÄ
  • VIETNAM
  • YHDYSVALLAT
Lisätietoja The IDPC has two types of membership. Partner members work together to implement the annual IDPC work plan, while network members contribute to the dissemination of our ideas and materials. We come together to facilitate open debate on drug policy issues, and to promote more humane and effective policy at a national and international level.

For a full list of IDPC Partner Members, please visit: http://idpc.net/members/partners

For a full list of IDPC Network Members, please visit: http://idpc.net/members/network

For more information on IDPC's membership criteria, please visit: http://idpc.net/members/membership-criteria

Verkostot

Tiedot siitä, kuuluuko organisaatio yhteen tai useampaan yhdistykseen/järjestöön/liittoon tai verkostoon vaikka vain epävirallisesti.




IDPC is a member of the European Civil Society Forum on Drugs, and of the Vienna NGO Committee on Drugs.

Rahoitustiedot

Tilikausi: 04/2012 - 03/2013
Kokonaisbudjetti: 747 446
josta julkista rahoitusta: 345 360
- EU-rahoitusta:
- Hankinnat:
- Avustukset: 21 861
- kansallisista rahoituslähteistä: 323 499
- paikallisista/alueellisista rahoituslähteistä:
muista rahoituslähteistä: 402 086
- lahjoitukset ja avustukset:
- jäsenmaksut:
grants (OSF, Getty Foundation, AUSAID, AMFAR, RCNF) : 402 086
Arvio organisaation EU:n toimielimissä harjoittamaan suoraan edunvalvontaan liittyvistä kustannuksista tämän tilikauden aikana: >= 50000  € - < 100000  €
Lisätietoa rahoituksesta tai muita avoimuuden kannalta tärkeitä tarkennuksia:


Rekisterin säännöt

Ilmoittautumalla rekisteriin organisaatio on hyväksynyt avoimuusrekisterin hyvän edunvalvontatavan.